![Thomas Englese](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Thomas Englese
Direttore/Membro del Consiglio presso Therakos (UK) Ltd.
Posizioni attive di Thomas Englese
Società | Posizione | Inizio | Fine |
---|---|---|---|
Therakos (UK) Ltd.
![]() Therakos (UK) Ltd. Medical/Nursing ServicesHealth Services Founded in 2012, Therakos (UK) Ltd. is a subsidiary of Mallinckrodt Plc. The company is based in Staines-upon-Thames, UK. The British company develops immune cell therapies that are delivered through extracorporeal photopheresis. | Direttore/Membro del Consiglio | 30/10/2015 | - |
Storia della carriera di Thomas Englese
Precedenti posizioni note di Thomas Englese
Società | Posizione | Inizio | Fine |
---|---|---|---|
MALLINCKRODT PLC | Corporate Officer/Principal | 01/04/2015 | 01/07/2019 |
IKARIA, INC. | Corporate Officer/Principal | 01/10/2008 | 01/03/2015 |
BAXTER INTERNATIONAL INC. | Corporate Officer/Principal | 01/01/2002 | 01/01/2008 |
ELUTIA INC. | Corporate Officer/Principal | 01/07/2019 | - |
Formazione di Thomas Englese
The Pennsylvania State University | Masters Business Admin |
Villanova University | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 6 |
Irlanda | 2 |
Regno Unito | 2 |
Posizioni
Corporate Officer/Principal | 4 |
Director/Board Member | 1 |
Masters Business Admin | 1 |
Settori
Health Technology | 5 |
Consumer Services | 3 |
Health Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 3 |
---|---|
BAXTER INTERNATIONAL INC. | Health Technology |
MALLINCKRODT PLC | Health Technology |
ELUTIA INC. | Health Technology |
Aziende private | 2 |
---|---|
Ikaria, Inc.
![]() Ikaria, Inc. BiotechnologyHealth Technology Ikaria, Inc. operates as a biotherapeutics company focused on developing and commercializing innovative therapeutics and interventions designed to meet the medical needs of critically ill patients. It offers INOMAX for inhalation, which is used to treat newborns suffering from hypoxic respiratory failure, and is making a major impact on the critical care environment. The company was founded on August 18, 2006 and is headquartered in Clinton, NJ. | Health Technology |
Therakos (UK) Ltd.
![]() Therakos (UK) Ltd. Medical/Nursing ServicesHealth Services Founded in 2012, Therakos (UK) Ltd. is a subsidiary of Mallinckrodt Plc. The company is based in Staines-upon-Thames, UK. The British company develops immune cell therapies that are delivered through extracorporeal photopheresis. | Health Services |
- Borsa valori
- Insiders
- Thomas Englese
- Esperienza